VentriPoint Diagnostics (TSE:VPT) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Ventripoint Diagnostics has announced the submission of its AI-enhanced heart-scanning technology, VMS+4.0, for EU MDR certification, indicating a pivotal advancement in its regulatory journey. The VMS+4.0 system streamlines clinical workflow with minimal manual input and is already in use across various countries, awaiting further approval in the EU.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
